198 related articles for article (PubMed ID: 37368093)
21. Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer.
Sah BK; Zhang B; Zhang H; Li J; Yuan F; Ma T; Shi M; Xu W; Zhu Z; Liu W; Yan C; Li C; Liu B; Yan M; Zhu Z
Nat Commun; 2020 Nov; 11(1):6093. PubMed ID: 33257672
[TBL] [Abstract][Full Text] [Related]
22. A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma.
Park I; Ryu MH; Choi YH; Kang HJ; Yook JH; Park YS; Kim HJ; Jung HY; Lee GH; Kim KC; Kim BS; Kang YK
Cancer Chemother Pharmacol; 2013 Oct; 72(4):815-23. PubMed ID: 23921575
[TBL] [Abstract][Full Text] [Related]
23. Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy.
Shitara K; Chin K; Yoshikawa T; Katai H; Terashima M; Ito S; Hirao M; Yoshida K; Oki E; Sasako M; Emi Y; Tsujinaka T
Gastric Cancer; 2017 Jan; 20(1):175-181. PubMed ID: 26626800
[TBL] [Abstract][Full Text] [Related]
24. Long-term Results of a Phase II Study of Neoadjuvant SOX for Advanced Gastric Cancer.
Ito S; Kuramochi H; Serizawa A; Ota M; Katagiri S; Maeda S; Hosoda K
Anticancer Res; 2024 Jan; 44(1):195-204. PubMed ID: 38160004
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinoma.
Honma Y; Yamada Y; Terazawa T; Takashima A; Iwasa S; Kato K; Hamaguchi T; Shimada Y; Ohashi M; Morita S; Fukagawa T; Machida N; Katai H
Surg Today; 2016 Sep; 46(9):1076-82. PubMed ID: 26563224
[TBL] [Abstract][Full Text] [Related]
26. Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer.
Petrioli R; Marrelli D; Roviello F; D'Ignazio A; Torre P; Chirra M; Savelli V; Ambrosio MR; Francini G; Calomino N; Farsi M; Vernillo R; Francini E
Surg Oncol; 2020 Mar; 32():2-7. PubMed ID: 31670056
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
[TBL] [Abstract][Full Text] [Related]
28. Safety and Efficacy of Neoadjuvant Chemotherapy for Advanced Gastric Cancer in Elderly Patients.
Mukoyama T; Kanaji S; Sawada R; Harada H; Urakawa N; Goto H; Hasegawa H; Yamashita K; Matsuda T; Oshikiri T; Kakeji Y
Anticancer Res; 2023 Dec; 43(12):5649-5656. PubMed ID: 38030165
[TBL] [Abstract][Full Text] [Related]
29. Phase I study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PI).
Satake H; Miki A; Kondo M; Kotake T; Okita Y; Hatachi Y; Yasui H; Imai Y; Ichikawa C; Murotani K; Hashida H; Kobayashi H; Kotaka M; Kato T; Kaihara S; Tsuji A
ESMO Open; 2017; 2(1):e000130. PubMed ID: 28761726
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy and safety of SOX regimen as neoadjuvant chemotherapy for advanced gastric cancer].
Li T; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Feb; 14(2):104-6. PubMed ID: 21365500
[TBL] [Abstract][Full Text] [Related]
31. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.
Ito S; Sano T; Mizusawa J; Takahari D; Katayama H; Katai H; Kawashima Y; Kinoshita T; Terashima M; Nashimoto A; Nakamori M; Onaya H; Sasako M
Gastric Cancer; 2017 Mar; 20(2):322-331. PubMed ID: 27299887
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M
World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213
[TBL] [Abstract][Full Text] [Related]
33. [Safety and efficacy of laparoscopic surgery in locally advanced gastric cancer patients with neoadjuvant chemotherapy combined with immunotherapy].
Lv JB; Yin YP; Zhang P; Cai M; Chen JH; Li W; Li G; Wang Z; Wang GB; Tao KX
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jan; 26(1):84-92. PubMed ID: 36650004
[No Abstract] [Full Text] [Related]
34. Short-term outcomes of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 for gastric cancer with extensive lymph node metastasis (JCOG1704).
Kurokawa Y; Doki Y; Kitabayashi R; Yoshikawa T; Nomura T; Tsuji K; Goto M; Cho H; Hihara J; Hiki N; Nunobe S; Mizusawa J; Boku N; Terashima M
Gastric Cancer; 2024 Mar; 27(2):366-374. PubMed ID: 38180622
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
[TBL] [Abstract][Full Text] [Related]
36. Phase II study of S-1 plus oxaliplatin 130 mg/m
Kito Y; Machida N; Kawai S; Hamauchi S; Tsushima T; Todaka A; Yokota T; Yamazaki K; Fukutomi A; Onozawa Y; Tsuji K; Doyama H; Haraguchi Y; Nakashima K; Kunieda K; Taku K; Mori K; Yasui H
Int J Clin Oncol; 2018 Dec; 23(6):1084-1089. PubMed ID: 29931597
[TBL] [Abstract][Full Text] [Related]
37. FLOT Neoadjuvant Chemotherapy Followed by Laparoscopic D2 Gastrectomy in the Treatment of Locally Resectable Advanced Gastric Cancer.
Zhang S; Yan D; Sun Q; Du T; Cao D; Yang Y; Yuan B; Li H; Jiang X; Song C
Can J Gastroenterol Hepatol; 2020; 2020():1702823. PubMed ID: 32566545
[TBL] [Abstract][Full Text] [Related]
38. A Phase II Study of Perioperative Capecitabine plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601).
Terazawa T; Matsuyama J; Goto M; Kawabata R; Endo S; Imano M; Fujita S; Akamaru Y; Taniguchi H; Tatsumi M; Lee SW; Kurisu Y; Kawakami H; Kurokawa Y; Shimokawa T; Sakai D; Kato T; Fujitani K; Satoh T
Oncologist; 2020 Feb; 25(2):119-e208. PubMed ID: 32043772
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
